1-2 of 2
Authors: David S. Shames
Save search
Sort by
Journal Article

A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer Free

PDF
Johanna C. Bendell and others
The Oncologist, Volume 22, Issue 3, March 2017, Pages 264–271, https://doi.org/10.1634/theoncologist.2016-0223
Published: 16 February 2017
Journal Article

A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction Free

PDF
Manish A. Shah and others
The Oncologist, Volume 21, Issue 9, September 2016, Pages 1085–1090, https://doi.org/10.1634/theoncologist.2016-0038
Published: 08 July 2016